The ADA gene helps your body clear away certain natural chemicals so immune cells can grow and survive. This gene plays an important role in keeping the immune system working, especially in early life. When both copies do not work, these chemicals build up and can damage white blood cells, causing ADA deficiency, a form of severe combined immunodeficiency. Babies may have frequent infections, poor growth, and trouble fighting everyday germs.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Other genes mainly regulate when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
ADAGene function
What if the gene works
The ADA gene helps break down certain natural cell chemicals. This supports healthy immune cells, especially developing lymphocytes, and helps protect tissues from buildup that can harm cells.
Risk
What if the gene does not work
Variants in the ADA gene often cause ADA deficiency, leading to a very weak immune system with early, repeated infections and poor growth. Milder variants may lead to later onset or less pronounced immune problems.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the ADA gene can directly shape treatment, because ADA deficiency has gene-specific options. Management may include ADA enzyme replacement and, in some settings, gene therapy using your own stem cells. Stem cell transplant is also a standard option, and the best approach depends on donor availability, age, overall health, and local access.
Conditions associated with ADA
Gene function
What if the gene works
Your cells use the ADA gene to break down certain natural chemicals that form when DNA is made and recycled. This cleanup job is especially important for white blood cells, which need a balanced internal environment to grow and work well. Understanding ADA gene function in the immune system helps explain how the body supports everyday immune activity.
The ADA gene helps cells break down adenosine and deoxyadenosine, which are natural chemicals made during normal cell activity. This keeps these substances from building up as DNA is made and recycled.
By processing used DNA building blocks, the ADA gene supports the body's recycling system for nucleic acids (the material that makes up DNA and RNA). This helps cells reuse materials in a controlled way.
White blood cells rely on the ADA gene to keep their internal environment balanced while they grow and divide. This is especially important for T cells, a type of white blood cell that helps coordinate immune responses.
Adenosine also acts as a signaling molecule between cells. By clearing extra adenosine, the ADA gene helps keep those signals within a normal range.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human variation, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not cause any noticeable change and are part of the usual range of genetic variation. At times, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ADA gene can change the enzyme’s shape, stability, or amount, so cells clear adenosine related waste less effectively. This ADA gene variant effect on enzyme activity can let waste build up inside developing immune cells and interfere with their survival. Milder variants often preserve some enzyme function, while more severe variants can nearly abolish it. That difference can influence whether ADA deficiency appears later and more mildly or begins earlier with broader immune effects.
How variants are linked to conditions
Among the conditions linked to variants in the ADA gene, the best established is ADA severe combined immunodeficiency (ADA-SCID), an inherited immune condition that often appears in infancy. Some people with other pathogenic variants in the ADA gene develop a later-onset or milder combined immunodeficiency. This is a direct gene-disease link that can confirm a diagnosis, rather than a small risk change for a common illness.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ADA, risk is mostly determined by the variants inherited in the gene. A child’s chance is higher when both parents carry an ADA variant, and people born with two disease-causing ADA variants are very likely to develop the condition. Avoiding infections and getting close medical follow-up can help lower complications, but this does not change the underlying genetic risk.
Inheritance of ADA variants
ADA-related conditions are usually inherited in an autosomal recessive pattern. This means a child needs to inherit two ADA gene variants, one from each parent, to be affected, while parents with one variant are typically carriers. For families wondering how ADA gene variants are inherited, each pregnancy between two carriers has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with no familial variant. Because the ADA gene is on an autosome rather than a sex chromosome, this pattern is the same for boys and girls.
What does my ADA result mean for my family?
For families with an ADA-related condition, brothers and sisters may also be affected or may carry the same gene change, even if they feel well. Parents are usually healthy carriers, and other relatives may be carriers too. Because of this, close family members may want to discuss family testing with their care team or a genetic counselor.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the ADA gene, ADA genetic testing uses a blood or saliva sample. A laboratory reads the gene’s DNA sequence and compares it with the usual sequence to identify variants. Results can show whether a disease-causing ADA variant is present.
When should I consider getting a genetic test?
Consider ADA genetic testing if a baby or child has signs of a very weak immune system, such as serious repeated infections, poor growth, or an abnormal newborn screening result. Testing can also help if this immune condition runs in your family or if both parents are known ADA carriers.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies with the condition and the specific type of variant. Over time, how the body works is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds at the drug’s target. This is common and can help explain why the same medication works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how the body processes a drug and how strong its effects are. This information can support more informed and individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the ADA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. Talk with your doctor if you have concerns about side effects, unusual reactions, or how well a medicine is working. ADA has been studied in early research on response to some medicines, including methotrexate, but this is not part of routine care.
History
Throughout history, people have described children with severe, repeated infections long before the cause was clear. In the 1970s, researchers linked some of these cases to changes in the ADA gene, helping define a form of severe combined immunodeficiency, or SCID. This was a major step because it connected a specific inherited condition to a single gene. Building on this early work, scientists developed new treatment approaches, including one of the first widely recognized human gene therapy efforts in 1990 for ADA related SCID. That milestone made the ADA gene part of the early story of modern gene therapy. Over time, the history of the ADA gene has come to represent both progress in genetic diagnosis and the growth of targeted treatment.